Avalo Therapeutics (AVTX) Non-Current Deferred Tax Liability (2017 - 2026)
Avalo Therapeutics (AVTX) posted Non-Current Deferred Tax Liability of $463,000 for Q2 2026, up 58.0% from $293,000 a year earlier and up 3.8% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
At the end of FY2025, Avalo Therapeutics' Non-Current Deferred Tax Liability came in at $434,000, up 60.7% from FY2024.
- Annual Non-Current Deferred Tax Liability has increased for eight consecutive years, with a five-year compound annual growth rate of 37.0% (FY2020 to FY2025).
- In prior years, Avalo Therapeutics' Non-Current Deferred Tax Liability was $270,000 in FY2024 (+74.2%), $155,000 in FY2023 (+9.9%), $141,000 in FY2022 (+24.8%) and $113,000 in FY2021 (+25.6%).
- The Q2 2026 figure stands as the highest quarterly Non-Current Deferred Tax Liability in data going back to Q4 2017.
- On a year-over-year basis, Non-Current Deferred Tax Liability has increased in each of the last seven quarters, with growth averaging 61.3% over the last eight quarters.
- The strongest year-over-year quarter for Non-Current Deferred Tax Liability in the past five years was Q3 2025, with growth of 97.4%; the weakest was Q3 2024, with a decline of 6.1%.
- According to Business Quant data, Non-Current Deferred Tax Liability for the three prior quarters was $446,000 (Q1 2026), $434,000 (Q4 2025) and $304,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Avalo Therapeutics | 668.42 Mn | 668.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 463,000.00 |
| Mar 31, 2026 | 446,000.00 |
| Dec 31, 2025 | 434,000.00 |
| Sep 30, 2025 | 304,000.00 |
| Jun 30, 2025 | 293,000.00 |
| Mar 31, 2025 | 278,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Sep 30, 2024 | 154,000.00 |
| Jun 30, 2024 | 168,000.00 |
| Mar 31, 2024 | 162,000.00 |
| Dec 31, 2023 | 155,000.00 |
| Sep 30, 2023 | 164,000.00 |
| Jun 30, 2023 | 156,000.00 |
| Mar 31, 2023 | 148,000.00 |
| Dec 31, 2022 | 141,000.00 |
| Sep 30, 2022 | 133,000.00 |
| Jun 30, 2022 | 128,000.00 |
| Mar 31, 2022 | 122,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Sep 30, 2021 | 130,000.00 |
API Access
Avalo Therapeutics Non-Current Deferred Tax Liability API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deferred-tax-liability", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();